Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Kite Pharma: Highlights of October 18, 2016 Analysts' Day- I Remain More Cautious on the Stock than Mainstream Wall Street Analysts (KITE, Avoid, $46.45)

Key Points;

The most important data point between now and yearend 2016 is release of data from ZUMA-1 that shows…
Read more…